|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for NOVO NORDISK A S (NYSE:NVO) Stock.
NVO stock opening price was $65.25 per share.
Current price of NYSE:NVO Stock is $65.61 per share
and it is
$+0.61, (+0.94%) today
and it was trading in the daily range of $65.08 - 65.69 per share.
Current Bid Price for (NYSE:NVO) stock is $63.47 and the Ask Price is $67.67. In the last 52 weeks
NVO stock was trading in the range of $41.35 - 66.18. 50-Day Moving Average for (NYSE:NVO) stock is
$63.9068 and 200-Day Moving Average is $58.0267. On average analysts predict that One Year Target Estimated price for
(NYSE:NVO) stock is $64.95.
NOVO NORDISK A S (NYSE:NVO) Market capitalization is $39.130B. (NYSE:NVO) stock average daily volume is
163,120 shares per day.
However, on last trading session of Nov 13, 2009
NVO stock traded 228,559 shares.
Also The Short Ratio for (NYSE:NVO) stock is 3.60.
On previous trading session NVO Stock closed at $65.00 per share.
Last year NOVO NORDISK A S (NYSE:NVO) before taxes (EBITDA) (ttm) earned $3.517B on total revenue of $10.180B.
Earnings Per Share - EPS (ttm) for NVO stock is 3.56.
Also, (NYSE:NVO) Stock Price Per Earnings ratio - P/E is 18.26.
Thus, (NYSE:NVO) Stock Price/Sales (ttm) ratio is 3.81 and Price/Book (mrq) ratio is 5.52.
(NYSE:NVO) Stock pays a dividend of $1.034 per share which is a yield of 1.59%.
So at this time (NYSE:NVO) Stock maintains Trailing Annual Dividend Rate at 1.034
.
StockRing Recommendations for NOVO NORDISK A S (NYSE:NVO) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=NVO
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
NVO Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
| |
1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
NVO Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
Last Trade: |
65.61 |
Trade Time: |
Nov 13 |
Change: |
+0.61, (+0.94%) |
Prev Close: |
65.00 |
Open: |
65.25 |
Bid: |
63.47 |
Ask: |
67.67 |
1y Target Est: |
$64.95 |
50-Day Moving Average: |
63.9068 |
200-Day Moving Average:
|
58.0267 |
Short Ratio: |
3.60 |
Trailing Annual Dividend Rate: |
1.034
|
|
Day's Range: |
65.08 - 65.69 |
52wk Range: |
41.35 - 66.18 |
Volume: |
228,559 |
Avg Vol: |
163,120 |
Market Cap: |
39.130B |
P/E (ttm): |
18.26 |
EPS (ttm): |
3.56 |
Div & Yield: |
1.034 (1.59%) |
Revenue (ttm): |
10.180B |
Earnings before Tax (EBITDA) (ttm): |
3.517B |
Price/Sales (ttm): |
3.81 |
Price/Book (mrq): |
5.52 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
NOVO NORDISK A S (NYSE: NVO) Company Information
Novo Nordisk A/S
Novo Alle
Bagsvaerd, 2880
Denmark - Map
Phone: 45 44 44 88 88
Fax: 45 44 49 05 55
Web Site: http://www.novonordisk.com
NOVO NORDISK A S (NYSE: NVO) DETAILS
NOVO NORDISK A S (NYSE: NVO) Index Membership: N/A
NOVO NORDISK A S (NYSE: NVO) Sector: Healthcare
NOVO NORDISK A S (NYSE: NVO) Industry: Drug Manufacturers - Other
NOVO NORDISK A S (NYSE: NVO) Full Time Employees: 28,497
NOVO NORDISK A S (NYSE: NVO) BUSINESS SUMMARY
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulin franchise, including modern insulins, human insulins, insulin-related sales, and oral antidiabetic drugs, as well as GLP-1 compounds in development for both the treatment of type 2 diabetes and as an anti-obesity agent. The Biopharmaceuticals segment provides products in the areas of haemostasis management, growth hormone therapy, hormone replacement therapy, inflammation therapy, and other therapy areas. The company sells its products principally in the United States, Japan, China, the Russian Federation, India, Turkey, and other European countries. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.
NOVO NORDISK A S (NYSE: NVO) KEY EXECUTIVES, SALARIES and BONUSES
Mr. Lars Rebien Sørensen , Age: 54
Chief Exec. Officer and Pres Salary: N/A Bonus: N/A
Mr. Jesper Brandgaard MSc, Age: 46
Chief Financial Officer, Exec. VP, Chairman of Novo Nordisk Engineering A/S and Chairman of Novo Nordisk IT A/S Salary: N/A Bonus: N/A
Mr. Kåre Schultz , Age: 48
Chief Operating Officer and Exec. VP Salary: N/A Bonus: N/A
Mr. Kurt Anker Nielsen M.Com.,Age: 63
Director, Chairman of Audit Committee and Chief Exec. Officer of Novo A/S Salary: N/A Bonus: N/A
Dr. Mads Krogsgaard Thomsen Ph.D., Age: 49
Chief Science Officer and Exec. VP Salary: N/A Bonus: N/A
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Novo Nordisk A/S: Transaction in Own Shares
Market Wire - Nov 9, 2009
BAGSVAERD, DENMARK--(Marketwire - November 9, 2009) - On 7 August 2009 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's ...
SEB cuts target on Novo Nordisk to DKK400
Trading Markets - Nov 2, 2009
Nov 02, 2009 (M2 PRESSWIRE via COMTEX) -- NVO -- 2 November 2009 - SEB reduced the share price target on Danish pharma company Novo Nordisk A/S (CPH: NOVO B) to DKK400 from DKK415 but retained the ...
Novo Nordisk net profit rises to DKK8.4bn 9-mo '09
Trading Markets - Oct 29, 2009
Oct 29, 2009 (M2 PRESSWIRE via COMTEX) -- NVO -- 29 October 2009 - Danish pharma major Novo Nordisk A/S (CPH: NOVO B) reported today a 15% rise in net profit to DKK8.445bn in the first nine months ...
3 Euro Stocks With Rising Dividends
Smartmoney.com - Oct 27, 2009
To secure healthy dividend yields and sidestep the ailing US dollar, look to European aristocracy. I refer not to Windsors and Borbóns but to Nestle and Novartis, and to the 38 other members of ...
|
|
More Alchevsk Steelworks ordersSteelGuruAccording to Sumy NVO press service release, the Company has shipped equipment for the two blocks of the gas turbine station at Alchevsk Steelworks for a ... |
|
|
No comments:
Post a Comment